Tag: Anne S. De Groot
EpiVax out-licenses COVID-19 vaccine candidate
PROVIDENCE – EpiVax Inc. has out-licensed its COVID-19 vaccine candidate to EpiVax Therapeutics, based in New York.
EVT, a venture-backed company that was previously named...
EpiVax and CUBRC win $1M FDA contract to establish best practices...
PROVIDENCE – EpiVax Inc. and CUBRC Inc. have been awarded a two-year, $1 million federal contract from the U.S. Food and Drug Administration to...
EpiVax wins $324K NIH grant to improve Pompe disease treatment
PROVIDENCE — EpiVax Inc. has received a $324,980 Small Business Innovation Research grant to continue development of a web-based test for people at risk...
Renowned vaccine researcher Dr. Anne S. De Groot is ready to...
In 1997, Dr. Anne S. De Groot founded EpiVax Inc. in Providence, backed by a Small Business Innovation Research grant from the National Institutes...
Public investment in basic research yields major victories
Dr. Anne S. De Groot is a major success story, not just in Rhode Island but across the globe.
She bridges the research and clinical...
Small companies, 18, EpiVax Inc.
Employees in R.I.: 24
Founder, CEO and Chief Science Officer Dr. Anne S. De Groot
Questions answered by: Stephanie Vece, human resources manager
What three words best...
- Featured Event -
